Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Hemorrhage 6Leiomyoma 3Hematologic Neoplasms 3Urinary Bladder Neoplasms 2Seizures 2Postoperative Hemorrhage 2Ovarian Neoplasms 2Neoplasms 2Menorrhagia 2Urologic Diseases 1Urinary Tract Infections 1Urinary Retention 1Thromboembolism 1Thrombocytopenia 1Staphylococcal Infections 1Spasm 1Sleep Initiation and Maintenance Disorders 1Seroma 1Sepsis 1Schizophrenia, Treatment-Resistant 1Schizophrenia 1Retinitis 1Renal Insufficiency, Chronic 1Pulmonary Arterial Hypertension 1Prostatic Neoplasms 1Postoperative Complications 1Pneumonia 1Patient Satisfaction 1Pain 1Osteosarcoma 1

Interventions

Gemcitabine 79Cisplatin 56pembrolizumab 32Paclitaxel 28Carboplatin 24Docetaxel 19Radiotherapy 17Mitomycin 16Doxorubicin 15atezolizumab 14BCG Vaccine 14Nivolumab 13Cystectomy 13Filgrastim 11vinflunine 10Methotrexate 10Vinblastine 9Fluorouracil 95-aminolevulinic acid hexyl ester 9Sunitinib 7Early Intervention, Educational 7durvalumab 6avelumab 6Taxes 6Methods 6Cystoscopy 6Albumin-Bound Paclitaxel 6enfortumab vedotin 5Trastuzumab 5Surveys and Questionnaires 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Urinary Bladder Neoplasms × Tranexamic Acid × Clear all
NCT01869413 2022-10-04

TACT

Ottawa Hospital Research Institute

Phase 2/3 Completed
354 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT04555343 2021-11-05

Intravesical Antifibrinolytic for Patients With Hematuria and Clot Retention

Fraser Health

Phase 1/2 Completed
14 enrolled
Genitourinary

Urinary Bladder Neoplasms, Hematuria, Prostatic Neoplasms, Urologic Diseases, Urinary Retention, Patient Satisfaction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡